Review of gemcitabine in biliary tract carcinoma

被引：55
作者：
Scheithauer, W [1 ]
机构：
[1] Univ Vienna, Dept Internal Med 1, Div Oncol, Sch Med, A-1090 Vienna, Austria
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1016/S0093-7754(02)70025-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 45
页数：6
相关论文
共 39 条
[1]  
ANDRE T, 2001, EJC SUPPL, V37, P19
[2]  
ARROYO G, 2001, P AN M AM SOC CLIN, V20, pA626
[3]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413
[4]  
CARRARO S, 2001, P AN M AM SOC CLIN, V20, pA2333
[5]  
Castro MP, 1998, CANCER, V82, P639, DOI 10.1002/(SICI)1097-0142(19980215)82:4<639::AID-CNCR4>3.0.CO
[6]  
2-G
[7]  
CSOKA K, 1995, SEMIN ONCOL, V22, P47
[8]   Medical progress - Biliary tract cancers [J].
de Groen, PC ;
Gores, GJ ;
LaRusso, NF ;
Gunderson, LL ;
Nagorney, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) :1368-1378
[9]  
DESTOLL M, 1785, RATIONIS MENDENDI 1
[10]  
Dobrila-Dintinjana R., 2000, American Journal of Gastroenterology, V95, P2476
1234